|1||NCT00097188||Completed||A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis||
||104||All||18 Years to 55 Years (Adult)||NCT00097188||U2787g||December 2004||December 2006||November 19, 2004||March 4, 2014||
|2||NCT02833714||Terminated||Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.||
||Other / Industry||
||26||All||18 Years to 55 Years (Adult)||NCT02833714||14-2877||January 2016||December 21, 2016||December 21, 2016||July 14, 2016||September 15, 2017||
† Study has passed its completion date and status has not been verified in more than two years.